Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 11:23 PM
Study NCT ID:
NCT01497093
Status:
COMPLETED
Last Update Posted:
2020-04-07
First Post:
2011-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-20
First Submit QC Date:
None
Study First Post Date:
2011-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-03
Last Update Post Date:
2020-04-07
Last Update Post Date Type:
ACTUAL